Menu
Contact

Inspire Medical Systems, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference

December 21, 2022

MINNEAPOLIS, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at the Westin St. Francis Hotel in San Francisco, CA. Inspire is scheduled to present at 8:15 a.m. Pacific Time. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com. About Inspire Medical SystemsInspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. For additional information about Inspire, please visit www.inspiresleep.com. Investor and Media ContactEzgi YagciVice President, Investor Relationsezgiyagci@inspiresleep.com617-549-2443

© 2024 BrandPublished.com